Article Versions Notes

Shaw J, Lai C, Bota P, Le A, Andricioaei A, Tran T, Allee T. The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations. Healthcare. 2025; 13(19):2433. https://doi.org/10.3390/healthcare13192433

Shaw, Jonathan, Charles Lai, Peter Bota, Andrew Le, Anton Andricioaei, Theodore Tran, and Tina Allee. 2025. "The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations" Healthcare 13, no. 19: 2433. https://doi.org/10.3390/healthcare13192433

Shaw, J., Lai, C., Bota, P., Le, A., Andricioaei, A., Tran, T., & Allee, T. (2025). The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations. Healthcare, 13(19), 2433. https://doi.org/10.3390/healthcare13192433